September 21, 2012, Brussels, Belgium and Schiedam, The Netherlands -- Ovizio Imaging Systems and Applikon Biotechnology jointly announce today the
signing of a long term worldwide marketing and distribution agreement for an
innovative device using a proprietary imaging technology in microscopy.
As part of the agreement, Applikon will globally market the innovative and
integrated solution, developed by Ovizio that combines 4D microscopic imaging
with the Applikon bioreactor systems. This new device will ofer automated on-line
information on cell density, cell viability and morphologic state of the cells.
“Applikon and Ovizio have a common vision of the potential of optical image
analysis in bioprocessing” said Erik Kakes, Commercial Director of Applikon
Biotechnology. "We feel that using optical 4D image analysis for determination of
biomass concentration and viability is only the ?rst step in applying this
revolutionary technology to the bioprocess industry", he added.
“We are absolutely delighted to partner with a company having such an in-depth
knowledge of the market and strong reputation within the Bioprocess industry”,
said Philip Mathuis, CEO of Ovizio. “We believe that quantitative imaging as a new
Process Analytical Technology (PAT) applied to on-line bioreactor monitoring will
allow Biopharma customers to improve process knowledge, quality and productivity
in their R&D, Pilot and Production environments.”
The new device will be jointly presented at the next “Het Instrument” Amsterdam,
exhibition on 26 September 2012.
About Applikon Biotechnology B.V.
Applikon Biotechnology BV (Schiedam, Netherlands) is a privately owned leading
supplier of bioreactor systems for the pharmaceutical and the biotechnological
market. We specialize in novel technologies in cultivation systems, measurement
and control for the biopharmaceutical industry. In the past years, Applikon
Biotechnology has built up a broad portfolio of unique bioprocessing devices for
both cell culture and microbial cultivation, and this has considerably set us apart
from the competition. We are de?nitely a step ahead.
To learn more about Applikon Biotechnology and their bioprocess solutions, visit
About Ovizio Imaging Systems NV/SA
Ovizio is a spin-of company of the “Université Libre de Bruxelles” (ULB). The
company designs, develops and markets 4-D quantitative imaging systems and
sensors based on patented Digital Holographic Microscopy with a primary focus on
the Life Science Research, Biotechnology and Bioprocessing industry.
Ovizio’s platform technology uni?es real-time quantitative imaging with speed and
a label-free, non-invasive approach. Our advanced devices generate high quality
holographic images ideal for studying dynamic phenomena, breaking the barriers
between the traditional speed of ?ow cytometry and the resolution of classical
Ovizio is a privately held company situated in Brussels, Belgium. For additional
information, visit www.ovizio.com.
Media and Business Contacts:
+31 10 20 83 555
+32 2 600 50 90